Posted on 8/11/20
OpenBeds Partners with the Alaska Department of Health and Social Services
OpenBeds, an Appriss Health company providing technology that identifies, unifies and tracks behavioral health resources to facilitate rapid digital treatment referrals, today announced it has partnered . . .
Posted on 8/11/20
Northwest Biotherapeutics Announces $8 Million Financing
Northwest Biotherapeutics (OTCQB: NWBO), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers
Posted on 8/11/20
States with the Fewest Coronavirus Restrictions – WalletHub Study
With many states delaying the later phases of their reopening or even bringing back restrictions they already lifted due to spikes in COVID-19, the personal-finance website . . .
Posted on 8/11/20
Why in the World Is Novavax Stock Up 4,000%?
Novavax (NASDAQ:NVAX) started off 2020 as a micro-cap. It was trading at $4 a share, and its market capitalization was barely over $100 million. The stock . . .
Posted on 8/11/20
Novavax Reports Second Quarter 2020 Financial and Operational Results
GAITHERSBURG, Md., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its . . .
Posted on 8/10/20
Senseonics Announces Strategic Collaboration with Ascensia Diabetes Care
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems . . .
Posted on 8/10/20
Novavax Secures $2B in Funding to Support COVID-19 Vaccine Development
Novavax (NASDAQ:NVAX) Q2 results:Revenue: $35.5M (+999%) from CEPI agreement.Net loss: ($17.5M); loss/share: ($0.30).Cash and equivalents at quarter-end: $424.4M (+438.6%).Secured $2B in funding to support development and . . .
Posted on 8/10/20
CASI Pharmaceuticals Announces Second Quarter 2020 Financial Results
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results and business highlights . . .
Posted on 8/10/20
Better Coronavirus Stock: Novavax or Vaxart?
Novavax (NASDAQ:NVAX) and Vaxart (NASDAQ:VXRT) have practically become household names in 2020, largely thanks to their efforts to develop vaccines for COVID-19. Both of these companies . . .
Posted on 8/10/20
Is Now the Right Time to Buy Novavax Stock?
One of the best-performing biotech stocks so far this year is Novavax (NASDAQ:NVAX). The company wasn't particularly well-known going into 2020, but its stock price has . . .
Posted on 8/10/20
Novavax Partners With Takeda to Sell Its Coronavirus Vaccine in Japan
Novavax (NASDAQ:NVAX) is teaming up with Japanese drug maker Takeda Pharmaceutical (NYSE:TAK) to sell Novavax's coronavirus vaccine, NVX-CoV2373, as a prevention for COVID-19 in Japan.Takeda will . . .
Posted on 8/9/20
Emergent BioSolutions Announces Upsize and Pricing of $450M of Senior Unsecured Notes
GAITHERSBURG, Md., (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has priced its offering of $450 million aggregate principal amount of 3.875% Senior . . .
Posted on 8/6/20
Emergent BioSolutions: The Indirect COVID-19 Vaccine Play Looks Undervalued
SummaryThe manufacturing deals for candidates set the stage for Emergent to ride the momentum of COVID-19 vaccine development.Until a winner emerges, its antibody therapy can be . . .
Posted on 8/6/20
Apex Physics Partners Announces Partnership With Alyzen Medical Physics
Apex Physics Partners (APP), a leading medical physics business services support organization, is proud to announce a new partnership with Alyzen Medical Physics, a leader in . . .
Posted on 8/6/20
Interview with Guy D’Andrea, Founder and Managing Partner of Discern Health
As all aspects of healthcare continue to evolve amidst the COVID-19 pandemic, there remains an opportunity for companies to provide an integrated approach across the health . . .
Posted on 8/6/20
Cerecor Reports Second Quarter 2020 Financial Results and Business Update
ROCKVILLE, Md. and CHESTERBROOK, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ : CERC), a leading biopharmaceutical company focused on development and commercialization of . . .
Posted on 8/6/20
Why Novavax Soared 71.7% in July
What happenedNovavax (NASDAQ:NVAX) shares surged 71.7% in July, according to data provided by S&P Global Market Intelligence, after the U.S. government offered the company $1.6 billion . . .
Posted on 8/5/20
Adaptive Phage Therapeutics Announces Mayo Clinic as Lead Investor in Convertible Note Financing
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic . . .
Posted on 8/5/20
Novavax's Coronavirus Vaccine Induced Antibodies in 100% of Phase 1 Trial Participants
Novavax (NASDAQ:NVAX) is trailing the leaders in the race to develop the first vaccine to protect against the novel coronavirus that causes COVID-19. But data from . . .
Posted on 8/5/20
Novavax On Wild After-Hours Ride After Reporting COVID-19 Vaccine Data
At one point after hours, Novavax (NASDAQ:NVAX) was down ~30% after STAT News reported that eight participants in a Phase 1 clinical trial evaluating COVID-19 vaccine . . .
Posted on 8/4/20
Novavax Rebounds from Vaccine Data-Stoked Selloff on Clarified Safety Profile
Novavax (NASDAQ:NVAX) announces positive results from the first portion of its Phase 1/2 clinical trial evaluating its COVID-19 vaccine candidate, NVX-CoV2373, with and without the Matrix-M . . .
Posted on 8/4/20
State-by-State Breakdown: COVID-19 Testing Positivity Rates in the Community & PPE Supply Shortages for Nursing Homes
Since July 26, there are 33 states with a positive test rate of over five percent, underscoring the urgent need for increased testing and PPE to . . .
Posted on 8/4/20
Emergent BioSolutions Announces Proposed Offering of $400 Million of Senior Unsecured Notes
GAITHERSBURG, Md., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it intends to offer $400 million aggregate principal amount of senior . . .
Posted on 8/3/20
HealthWell Foundation Opens New Fund to Assist B-Cell Lymphoma Patients
The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new fund to provide copayment and premium assistance . . .
Posted on 8/3/20
2020’s Best & Worst States for Health Care – WalletHub Study
The COVID-19 pandemic has impacted medical care in countless ways, from postponing elective surgeries to moving many visits online. To shed some light on where people . . .

